The real key is going to be side effects over time, if retatrutide is like other drugs in the class then the side effects should decrease with time, but unfortunately, we dont have that today, at this point I have some questions and minor concerns but without the data over time its hard to speculate about tolerability further beyond saying its similar to other drugs in the class
In detail, GLP-1 treatment leads to a decrease in M1 markers, including IL-6, TNF-, and inducible NOS ( i NOS), while promoting increased levels of markers of M2 such as IL-10, arginase-1(Arg-1), macrophage galectin-1 (MGL-1), and mannose receptor-1 (MRC-1) in murine RAW264.7 macrophages [14, 79]
Nearly all insurance plans will only cover weight loss drugs if you: Get prior authorization from the insurance company Meet the drug's weight criteria set by the FDA
End-to-end causal effect estimation from unstructured natural language data
Effectiveness was expressed in terms of Quality-Adjusted Life Years (QALYs)